Mitigation of pandemic influenza: review of cost-effectiveness studies

Anna K Lugnér, Maarten J Postma

    Research output: Contribution to journalArticleAcademicpeer-review

    19 Citations (Scopus)

    Abstract

    We conducted a review of economic evaluations of pandemic influenza control measures. In the studies found, we detected various interventions being investigated: antiviral stockpiling and treatment, prophylaxis, vaccination, school closure and restricting international travel. Cost-effectiveness varied but often showed potentials for the favorable economic profiles of these measures. Both static and dynamic models were used. We conclude that the choice of an appropriate model - in particular, a dynamic model - is crucial to arrive at valid cost-effectiveness ratios. Yet, of the economic evaluations considered here, only a few were based on dynamic modeling. We recommend that further research is directed toward linking dynamic epidemiological models for pandemic spread with economic outcomes by considering the full impacts on national economies, including direct, indirect, medical and nonmedical costs.

    Original languageEnglish
    Pages (from-to)547-558
    Number of pages12
    JournalExpert review of pharmacoeconomics & outcomes research
    Volume9
    Issue number6
    DOIs
    Publication statusPublished - Dec-2009

    Keywords

    • Antiviral Agents
    • Cost-Benefit Analysis
    • Disease Outbreaks
    • Humans
    • Influenza Vaccines
    • Influenza, Human
    • Models, Economic

    Cite this